Komori
Fuji Pharma (4554) · PolicyRestated

Change to the Straight-Line Depreciation Method Prompted by Equipment Investment at the Toyama Plant

First written in FY2021-Q1. 3 of 4 entries say "Restated". Latest entry: FY2021.

4entries
1years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021-Q1 – FY20212021: 42021
Same theme, other companies
Change in depreciation method prompted by capital investment at the Toyama PlantA theme 1 companies write about · 0 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2021RestatedAnnual report

    「The company previously used the declining-balance method to depreciate machinery and equipment, transportation equipment, and tools, fixtures and equipment included in other property, plant and equipment, but changed to the straight-line method from the current consolidated fiscal year.」

    Continues to disclose in the annual results the change from the declining-balance method to the straight-line method prompted by capital investment at the Toyama Plant and a review of actual use.
  2. FY2021-Q3RestatedAnnual report

    「The company previously used the declining-balance method to depreciate machinery and equipment, transportation equipment, and tools, fixtures and equipment included in other property, plant and equipment, but changed to the straight-line method from the first quarter of the current consolidated fiscal year.」

    Continues to disclose the change in the depreciation method from the declining-balance method to the straight-line method prompted by capital investment at the Toyama Plant.
  3. FY2021-Q2RestatedAnnual report

    「The company previously used the declining-balance method to depreciate machinery and equipment, transportation equipment, and tools, fixtures and equipment included in other property, plant and equipment, but changed to the straight-line method from the first quarter of the current consolidated fiscal year.」

    Continues to disclose this quarter the change from the declining-balance method to the straight-line method based on a review of actual use prompted by capital investment at the Toyama Plant.
  4. FY2021-Q1First statedAnnual report

    「The company previously used the declining-balance method to depreciate machinery and equipment, transportation equipment, and tools, fixtures and equipment included in other property, plant and equipment, but changed to the straight-line method from the first quarter of the current consolidated fiscal year.」

    For the first time, states that the depreciation method was changed from the declining-balance method to the straight-line method after reviewing the actual use of fixed assets in connection with capital investment at the Toyama Plant, because stable long-term operations are expected.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuji Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.